Spectroscopic MRI-Based Biomarkers Predict Survival for Newly Diagnosed Glioblastoma in a Clinical Trial is a research paper published in Cancers (2023). On theSindex it has a DataRank of 0.208. It has been cited 3 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.208
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →NIH
Grant: U01 CA264039
NIH
Grant: F31 CA247564
National Institutes of Health
Grant: 5U01CA264039-06
Improved whole-brain spectroscopic MRI for radiation therapy planning
National Institutes of Health
Grant: 1F31CA247564-01
Automated imaging analysis tools to guide clinical decision making in brain tumor patients
FWCI
0.50
Citation Percentile
0.6%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals